Microsoft word - cv patel

Rakesh C. Patel, M.D.
1812 North Mills Avenue
Orlando, FL 32803

Education:

Division of Urology, Department of Surgery
Current Position:
June 2003-present
University of Florida Urology Research Award, 2002
Licensure:


Book Chapters:

Endourological Management of Ureteral Strictures,
Rakesh C. Patel, M.D.
Professional
Associations:


American Urological Association
American College of Surgeons, Resident Candidate
Florida Urological Association

Academic
Appointments:

Associate Clinical Professor of Surgery-Division of Urology Presentations:

Perineal Prostatectomy, “How we do it and why” Department of General Surgery Grand Rounds Department of General Surgery Grand Rounds Testicular Cancer – Department of General Surgery Grand Rounds
Research:
2002
Ureteral Strictures in Kidney Transplant Recipients University of Florida Experience with Laparoscopic Donor Nephrectomies “A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Study Drug 0.5mg Administered Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable “An Open-Label Study to Evaluate the Efficacy and Safety of Study Drug Administered ‘On Demand’ to Men of Various Populations with Erectile Rakesh C. Patel, M.D.
Research:
“Open-Label Study of the Efficacy and Safety of 5mg and 10mg Study Drug in Patients with Overactive Bladder Symptoms” “A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Study Drug for the Prevention of “REALISE: Real Life Safety and Efficacy on Levitra®” “A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo And Safety of Study Drug Sustained Release in Subjects with “Study of Study Drug in Women of Different Demographic Co-morbidities with Stress Urinary Incontinence: “A Study to Compare the Safety and Efficacy of Once Daily Study Drug Versus Twice Daily Study Drug in the Treatment of Complicated “A Double-Blind, Randomized, Placebo-Controlled Trial of Elmiron® For The Treatment of Chronic, Non-Bacterial Prostatitis” “A Randomized, Double-Blind, Crossover Study to Evaluate the Duration of Erection Following Study Drug 10mg Administration For 4 Weeks in a Fixed-Dose Regimen Compared to Placebo in Males with ED” “An Open-Label, Multicenter Study to Assess the Efficacy and Safety of Daily Oral Administration of 5 and 10mg Study Drug in Patients Who Wish to Switch from Detrol LA for the Treatment of Overactive “Prospective, Observational Registry and Patient Survey of the Management Rakesh C. Patel, M.D.

Research:


2005-present
Double-Blind, Randomized, Parallel Study “A Multicenter, 2 Week, Double-Blind Study of XXXX 60mg QD Morning or In The Evening In Patients With Overactive Bladder” “A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of XXXX for the Prevention of Prostate Cancer in Men with High Grade Prostate Intraepithelial Neoplasia”

Source: http://www.urologyofflorida.com/sites/wpu.fpmg-drupalgardens.com/files/patel.pdf

Microsoft word - idowu et al pdf

African Journal of Biotechnology Vol. 10(9), pp. 1700-1704, 28 February, 2011 Available online at http://www.academicjournals.org/AJB ISSN 1684–5315 © 2011 Academic Journals Incidence and susceptibility pattern of clinical isolates from pus producing infection to antibiotics and Carica papaya seed extract A. O. Idowu*, B. B. Oluremi and N. I. Seidu Department of Pharma

Aviva actions croissance 2011-03-31.xls

Forme juridique Objectif de gestion Le FCP a pour objectif d’obtenir une performance supérieure à celle de l’indicateur de référence pour optimiser le rendement de contratsd'assurance-vie libellés en unités de compte relevant de l'option dite "DSK". Date de création Catégorie Engine - EuroPerformance Performances * Cumulées Classification AMF

Copyright © 2010-2014 Drug Shortages pdf